EVE Health GroupASX:EVE -5.00% Market Cap is A$7.05 Mil as of Jun. 29, 2026. The stock has 6 warning signs investors should review. Among 2,039 Consumer Packaged Goods companies, EVE Health Group ranks worse than 91.37% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). EVE Health Group's share price for the quarter that ended in Dec. 2025 was A$0.021. EVE Health Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 284.88 Mil. Therefore, EVE Health Group's market cap for the quarter that ended in Dec. 2025 was A$5.98 Mil.
EVE Health Group's quarterly market cap
declined
from Dec. 2024 (A$5.27 Mil) to Jun. 2025 (A$3.99 Mil) but then
increased
from Jun. 2025 (A$3.99 Mil) to Dec. 2025 (A$5.98 Mil).
EVE Health Group's annual market cap
stayed the same
from Jun. 2023 (A$5.27 Mil) to Jun. 2024 (A$5.27 Mil) but then
declined
from Jun. 2024 (A$5.27 Mil) to Jun. 2025 (A$3.99 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. EVE Health Group's Enterprise Value for Today is A$6.16 Mil.
EVE Health Group (ASX:EVE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
EVE Health Group Market Cap Related Terms
EVE Health Group Market Cap Historical Data
* Premium members only.
The historical data trend for EVE Health Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, EVE Health Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's Market Cap distribution charts can be found below:
* The bar in red indicates where EVE Health Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
EVE Health Group's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVE Health Group (ASX:EVE) has a Market Cap of A$7.05 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #1863 out of 2039 companies in the Consumer Packaged Goods industry, placing it in the top 91.4%.
Is EVE Health Group's Market Cap too high?
EVE Health Group's current Market Cap is A$7.05 Mil. Based on the distribution chart, EVE Health Group ranks #1863 out of 2039 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does EVE Health Group's Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #1863 out of 2039 companies for Market Cap. This places EVE Health Group in the lower half of its industry. The industry median Market Cap is 101.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 101.18, based on 2,039 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 101.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current Market Cap is A$7.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 90% above its estimated fair value. The current Market Cap is A$7.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current Market Cap is A$7.05 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 